Christopher M. Smith - Jan 3, 2022 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc (OCDX)

Role
Chairman and CEO, Director
Signature
/s/ Michael A. Schlesinger, Attorney-in-Fact
Stock symbol
OCDX
Transactions as of
Jan 3, 2022
Transactions value $
-$853,800
Form type
4
Date filed
1/5/2022, 03:23 PM
Previous filing
Aug 4, 2021
Next filing
Jun 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCDX Ordinary Shares, $0.00001 par value Options Exercise $1.26M +100K +27.22% $12.56 467K Jan 3, 2022 Direct
transaction OCDX Ordinary Shares, $0.00001 par value Sale -$2.11M -100K -21.4% $21.10 367K Jan 3, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCDX Stock Option Options Exercise $0 -100K -9.66% $0.00 936K Jan 3, 2022 Ordinary Shares, $0.00001 par value 100K $12.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
F3 Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.4000
F4 The stock option vests in three equal annual installments beginning on September 9, 2020.